Apr 12, 2021
The United States Agency for International Development (USAID) has tapped a consortium led by Cargill and including Ausvet, Heifer International, and the International Poultry Council (IPC) to improve livestock management and combat the threat of zoonotic diseases to both human and animal health. The five-year, $33 million Transformational Strategies for Farm Output Risk Mitigation (TRANSFORM) consortium will harness innovation to sustainably improve animal health, strengthen animal agriculture production systems in Asia and Africa and enhance global health security.
As a farm-based initiative, TRANSFORM will prioritize efforts to significantly decrease the risks of antimicrobial resistance (AMR) and zoonoses, diseases spread from animals to humans such as foodborne pathogens, anthrax and Avian and swine influenza. The group will also consider transboundary animal diseases (TADs,) such as foot-and-mouth disease and African swine fever. Scientists estimate that more tha
Majority of American s are Confused About Postbiotics, Prebiotics and Probiotics
mesabitribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mesabitribune.com Daily Mail and Mail on Sunday newspapers.
Dairy Dialog podcast 121: Tate & Lyle, Evolve Biosystems, Bridge Cheese
Dairy Dialog podcast 121: Tate & Lyle, Evolve Biosystems, Bridge Cheese This week we feature three interviews, with five guests. We have conversations with Timothy Brown, CEO of Evolve BioSystems and Pam Shepherd, managing director of Manna Tree; Jim Carr, PhD, director, sweeteners global ingredient technology and Abigail Storms, vice president of sweetener innovation at Tate & Lyle; and Michael Harte, managing director of Bridge Cheese. We also have our weekly look at the global dairy markets with Charlie Hyland at StoneX.
Evolve BioSystems announces investment from Cargill and Manna Tree for infant gut health probiotic
Evolve BioSystems announces investment from Cargill and Manna Tree for infant gut health probiotic US microbiome company Evolve BioSystems has announced that it completed a first close in a $55m Series D round of funding, led by Cargill, the global food, agricultural, financial and industrial products company and Manna Tree, an investment firm committed to improving human health.
The new capital will be used to help the company continue commercializing a next generation of probiotic capable of addressing a widespread deficiency in the infant gut microbiome. We are thrilled to announce our newest investors as we continue our quest to address this health crisis in newborns, said Timothy Brown, CEO of Evolve BioSystems.
Evolve BioSystems gets $55 million investment led by Cargill Evolve BioSystems has announced $55 million in funding from Cargill and a private equity firm to bring its infant probiotic to market scale.
Evolve Biosystems is an independent microbiome research company that was launched out of University of California, Davis in 2014. It was initially funded by the Bill & Melinda Gates Foundation. Also participating in the funding announced this week was investment firm Manna Tree.
Evolve BioSystems has concentrated on infant gut health and the importance of the
Bifidobacterium infantis species of gut microbe. Research has shown that this species predominates in the guts of babies that are breastfed. The bacterium preferentially feeds upon the otherwise undigestible human milk oligosaccharides (HMOs) found in breast milk.
vimarsana © 2020. All Rights Reserved.